Experiments with phorbol esters revealed that protein kinase C activity is not obligatory for the effect of PGI, on c-fos expression.
We conclude from these results that PGI,, a rapidly inactivated prostanoid, has a major impact on cellular oncogene expression and growth in mesenchymally derived cells. (Endocrinology 137: 4536-4541, 1996) P Gs ARE IMPORTANT local regulators of many cellular functions (1, 2). Because of their multiple biological actions, their application in medical treatment is wide-spread (3), although their exact mode of action remains to be clarified.
By activation of phospholipase A, (41, arachidonic acid, the prostanoid precursor, is released from membrane phospholipids and is further metabolized by the specific key enzymes, cyclooxygenases 1 and 2 (5). PGs exert their various biological activities via specific nuclear (6, 7) or G protein-coupled transmembrane receptors (8) inducing intracellular signal transduction cascades, including 1) Cazf signaling, 2) inositol trisphosphate production, 3) CAMP accumulation, and 4) activation of protein kinases.
Much information exists about the role of the prostanoid metabolites in bone formation and bone resorption and about the expression of specific receptors in bone cells (9,101. In the osteoblast-like cell line MC3T3-El, receptors have been described for PGE, (11, 12) and proposed for PGF,, as well as PGE,, which may be the same as the prostacyclin (PGI,) receptor (13, 14) . PGE, has been shown to stimulate DNA synthesis and collagen production in bone organ cultures (15) as well as in isolated primary osteoblasts in vi&o (16). Under most culture conditions, PGE, is a potent mitogen for bone cells. In addition, a large number of in uivo studies indicate that PGE, and PGE, can stimulate bone formation (for a review, see Ref.
9). Likewise, PGF,, induces mitogenesis in MC3T3-El cells and increases protein kinase C (PKC) activity (17).
In contrast to other PGs, the short half-lifed PGI, is not well studied in bone cells. It was shown to be produced in bone organ cultures (18, 19) . Furthermore, PGI, has been suggested as a mediator of stress, with a preferential role in adaptive bone remodeling (20) . Recently, we have shown that application of hydrostatic pressure to MC3T3-El cells resulted in a rapid increase in c-fos messenger RNA (mRNA) expression. This effect could be inhibited by indomethacin, indicating PGs as mediators. Radioimmunological analysis revealed that PGI, is a likely candidate in mediating the effect of hydrostatic compressive stress on bone cells by regulating the level of c-/bs mRNA (21).
PGI, is rapidly converted (half-life, 2-12 min) into its stable, but biologically inactive, metabolite 6-keto-PGF,,. This rapid inactivation makes PGI, a perfectly regulated system that allows activation of receptor proteins and pointed signaling within a short period of time only.
Cellular immediate-early genes such as c-fos and egr-1 are regulated by the concerted action of multiple signals. c-fos transgenic mice were shown to develop osteosarcoma, indicating the central role of this regulatory protein in skeletal growth and development (22, 23) . Egr-1, a nuclear Zr?+ finger protein and transcriptional regulator, was shown to be coregulated with c-fos in the developing mouse (24). Both immediate-early transcription factors serve as nuclear couplers of early cytoplasmic events to long term alterations in gene expression (25, 26) .
In this paper we show that the short half-lifed PGI, is a potent stimulator of protooncogene expression in rodent osteoblastic and fibroblastic cell lines.
Materials and Methods

Cell culture
The cell lines used were of osteoblastic and fibroblastic origin: the mouse osteoblast-like cell line MC3T3-El (donated by Dr. Kumegawa, Meikai University, Sakado, Japan), the rat osteosarcoma-derived cell line UMR-106 (kindly provided by H. J. Leis, University of Graz, Graz, Austria), and the mouse fibroblastic cell line NIH-3T3. All cell lines were seeded in tissue culture dishes (Corning, Corning, NY) at a density of about 75,000 cells/cm' and cultured in (YMEM (Sebak, Suben, Austria) supplemented with 5% FCS (Sebak) and 30 Fg/rnl gentamicin. The cells were kept in humidified air under 5% CO2 at 37 C. All cell lines were subcultured twice a week before reaching confluence. For induction experiments, the medium was changed to (YMEM supplemented with 0.1% BSA 4 h before the addition of the inducers. PGI, (Cayman Chemical Co., Ann Arbor, MI), PGE, (Upjohn, Puurs, Belgium), iloprost (Bomedin) a stable PGIZ analog (Schering, Vienna, Austria), or arachidonic acid (Siema Chemical Co., St. Louis, MO) were added at the concentrationsmdicated. Cycloheximide (Sigma) at a final concentration of 10 pg/ml and actinomycin D (Serva, Heidelberg, Germany) at 2 pg/ml were used as translational and transcriptional inhibitors, respectively. Indomethacin (1 PM; Sharp and Dohme, Munich, Germany) and the protein kinase inhibitor H-7 (20 PM; Calbiochem, San Diego, CA) were used for signal transduction studies. All inhibitors were added 20 min before the addition of PGI,. Phorbol ester [l PM; phorbol 1Zmyristate 13-acetate (PMA); Sigma] was used as a PKC activator and to downregulate PKC activity by long term treatment.
Northern blotting
Cytoplasmic RNA was isolated (27), and its total amount was estimated spectrophotometrically.
Ten micrograms of total RNA were applied to each lane of a 1% agarose gel containing 2.2 M formaldehyde (28). After electrophoresis, the RNAs were transferred to a nylon filter (GeneScreen, New England Nuclear Corp., Boston, MA). Hybridization was performed for lo-16 h in a solution consisting of 10% dextran sulfate, 500 pgg/ml sheared salmon sperm DNA, 1 M NaCl, and 1% SDS. As hybridization probes we used a rat egr-I complementary DNA (cDNA) BglII fragment and a mouse c-fos cDNA (29). To ensure even loading, we hybridized the same Northern blots using the entire rat glycerildehyde phosphate dehydrogenase (GAPDH) cDNA (GAPDH cDNA was kindlv urovided bv Dr. Busslinger, Institute of Molecular Pathology, Vienna, 'Austria). Probe labeling Gas performed by random primed labeling of the excised insert using a commercialll available kit (Boehringer Mannheim, Mannheim, Germany) with [a-Pldeoxy-CTP (3000 Ci/mmol; New England Nuclear). After stringency washes, the filters were evaluated in an Instant Imager (Packard Instrument Co., Meriden, CT). The bands were quantitated densitometrically, normalized to GAPDH, and expressed as a percentage of the control value. Data are presented as the mean ? SE of three or more separate experiments. Statistical significance was analyzed using ANOVA (post-hoc test, Fisher's protected least significant difference test).
pH]Thymidine incorporation experiments
Cells were seeded at a density of 20,000 cells/cm' in 24-multiwell plates and grown in orMEM supplemented with 5% FCS to near confluency. The medium was changed to serum-free LYMEM, and the culture was continued for an additional 24 h. Treatments were performed by adding PGI,, PGE, or arachidonic acid in &IEM for 24 h at the concentrations indicated. Ci/mmol; New England Nuclear) in olMEM was added to give a final concentration of 3 &i/ml for the last 5 h of incubation. The cell layers were washed three times with PBS, and incorporated [3H]thymidine was precipitated by adding 10% TCA. Thereaiter, the acid-precipitable material was dissolved in 250 ul 0.1 N NaOH at 60 C and transferred to TonCount microplates (Packard Instrument Co.). Liquid scintillation cockkil, Microscint-20 (Packard), was added, and incorporated J3H]thymidine was counted in a TopCounter (Packard). Statistical significance was analyzed using ANOVA (post-hoc test, Fisher's protected least significant difference test). Preparation of nuclear extracts MC3T3-El cells were grown to confluency in otMEM supplemented with 5% FCS. Afterward, the cells were starved in serum-free culture medium for 24-48 h. Nuclear extracts were prepared from untreated cells or cells treated with iloprost (Ilomedin) for 30 or 50 min. In brief, the cells were scraped in ice-cold PBS, collected by centrifugation, and resuspended on ice in 10 mM HEPES (pH 7.9), 1.5 mu MgCl,, and 10 mM KCl. The cells were homogenized in aglass Dounce homog&izer (Kontes Co., Vineland, NJ), and nuclei were collected by centrifugation at 3,000 X 9 for 20 mm. Nuclei were extracted in a high salt extraction buffer 120 mM HEPES (pH 7.9), 25% glycerol, 1.2 M KClrand 0.2 mM EDTAI for 30 min and pelleted at 25,000 X g for 30 min. Supernatants were dialyzed against extraction buffer substituted with 0.1 M KCl. The dialyzed proteins were stored frozen at -25 C.
Western immunoblotting
After estimation of the protein contents with bicinchoninic acid/ copper (II) sulfate (Sigma), 20 pg protein were applied per lane, and elecirophoresis was performed under denaturing condi&ons on 10% uolvacrvlamide-SDS gels according to the method of Laemmli (30). After A , semidry transfer to &rocellulose membranes (Immobilon-P, Millipore Intertech, Bedford, MA), the blots were probed with a c-Fos antibody (~~-52, Santa Cruz Biotechnolozv. Santa Cruz. CA) at a 1:lOO dilution and detected by a secondary antib& against rabbit IgG coupled to alkaline phosphatase (Boehringer). For estimation of the mol wt, a color marker (Sigma) was used.
Results
PG12 induced the ml&VA synthesis of the immediate-early genes c-fos and egr-1 in both osteoblastic and fibroblastic cell lines
The time course of c-fos mRNA induction in MC3T3-El cells treated with 2 X lop6 M PGI, is shown in Fig. 1A . The increase in c-fos r&WA was detectable after 10 min and reached a prominent peak after 25 min. Thereafter, the amount of c-fos mRNA declined rapidly to low levels at 60 . As a control for RNA loading, hybridizations using a GAPDH probe were performed. Arrows indicate the 28SllSS ribosomal RNA markers. B, Densitometric analysis of the Northern blots shown in A after normalization to GAPDH. Data are given as a percentage of the control value (mean ? SE; n = 4). ***, P < 0.001 (treated us. control).
min. The dose-response relationship was tested in MC3T3-El cells and the osteosarcoma cell line UMR-106. c-fos mRNA levels were detectable after 25 min of treatment with PGI, at concentrations as low as 2 X 10-l' and 2 X 10m9 M, but were markedly increased at higher concentrations (2 X 10e7 and 2 X 10e6 M). c-fos mRNA was undetectable in untreated controls (Fig. 2) . There was no difference in the dose response between UMR-106 cells and MC3T3-El cells. A comparable effect of PGI, on c-fos mRNA expression was observed in NIH-3T3 mouse fibroblasts (Fig. lB) , indicating that this effect is not a specific feature of osteoblasts.
As it is known that in skeletal regions undergoing substantial bone formation, egr-2 and c-fos genes are coregulated (24), we were interested in the effect of PGI, treatment on egr-1 expression. Indeed, the time course of egr-1 mRNA induction paralleled that described above for c-fos mRNA (Fig. 3, A and B) . MC3T3-El (Fig. 3A) as well as NIH-3T3 cells (Fig. 38 ) responded rapidly to PGI, treatment with an increase in egr-1 mRNA levels. This response was transient, with a maximum after 25 min and a decline thereafter.
Translational and transcriptional regulation of PGI,-induced c-fos mRNA expression was studied with cyclohexi- mide (CHX) and actinomycin D as translational and transcriptional inhibitors, respectively. In MC3T3-El cells, the addition of CHX (10 pg/ml) resulted in increased levels of c-fos mRNA (Fig. 4) . However, treatment with PGI, additionally increased the amount of c-fos mRNA. In the presence of CHX, the effect of PGI, on c-fos mRNA expression was more pronounced, indicating the lack of feedback regulation. These data suggest that de nova protein synthesis is not needed for the induction of c-fos mRNA by PGI,. In contrast, actinomycin D (2 pg/rnl), an inhibitor of RNA polymerase II, completely blocked the c-fos mRNA response. Consequently, actinomycin D was also a potent inhibitor of c-fos Recently, it was reported that arachidonic acid and PGE, have the capacity to increase c-fos mRNA expression in Swiss 3T3 fibroblasts (31). Therefore, we compared the effects of PGI, in MC3T3-El cells with those of PGE, or arachidonic acid (both at 2 X 1O-6 M). As shown in Fig. 5 , all three compounds induced c-fos mRNA expression after 30 min. As expected, the effect of arachidonic acid was markedly inhibited by indomethacin (1 PM). The response to PGE, treatment was significantly more pronounced than that to PGI, or arachidonic acid (Fig. 5) . Indomethacin had no influence on the effect of the prostanoids on oncogene expression after 30 min (see Fig. 7 ).
To show that c-fos induction at the mRNA level results in an increase in Fos protein, Western immunoblotting was performed. Two major proteins of the c-Fos family were detected after 30 and 50 min of PGI, (iloprost) treatment (Fig. 6) .
The signal transduction pathways involved in the effect of PGI, were tested using protein kinase inhibitors. Interestingly, the addition of H-7 (20 /AM), an inhibitor of PKC, and cyclic nucleotide-dependent protein kinases inhibited the effect of PGI, on c-fos mRNA expression in MC3T3-El as well as NIH3T3 cells (Fig. 7) . In another series of experiments (Fig.  81 , c-fos expression after treatment of MC3T3-El cells with phorbol ester (PMA) for 10, 20, and 30 min and 24 h was studied. As a short term effect (lo-30 min), stimulation of c-fos mRNA expression was found. In contrast, after 24 h, c-fos mRNA levels returned to the basal level, indicating the down-regulation of PKC activity, as described in other osteoblast cultures (32). However, c-fos expression at this time was inducible by PGI,, indicating the involvement of alternate signal transduction pathways. As expected, additional PMA treatment was not able to stimulate C-$X mRNA after 24 h of PKC down-regulation (data not shown). PGE2 is known to stimulate the proliferation of osteoblasts (16). In agreement with this finding, treatment of MC3T3-El cells with 2 X 10m5 M PGE, for 24 h si * F3Hlthymidine incorporation (Fig. 9) . [ P icantly increased HlThymidine incorporation was also significantly increased to the same extent by 2 X 10T5 M PGI, (Fig. 9) . This effect of PG12 on proliferation was dose dependent in the concentration range between 2 x 10m7 and 2 X low5 M (Fig. 9 As a control for RNA loading, hybridizations using a GAPDH probe were performed. Arrows indicate the 28S/18S ribosomal RNA markers. B, Densitometric analysis of the Northern blots shown in A after normalization to GAPDH. Data are given as a percentage of the control value (mean t SE; n = 3-4). ***, P < 0.001 (treated us. control); AAA, P < 0.001 (H-7 us. PGI,); 0, P = NS (us. control).
the precursor of prostanoid metabolites, had no effect on DNA synthesis over 24 h.
Discussion
The identification of protooncogene activators and the characterization of signal transduction mechanisms are fundamental for the understanding of cell regulation. We now present convincing data that PGI* acts as a potent protoon- cogene activator.
Hence, to the best of our knowledge no investigation has been performed to elucidate the effect of PGI, on oncogene expression. We show for the first time that PGI, regulates c-fos and egr-2 gene expression in rodent osteoblastic as well as fibroblastic cell lines within 30 min.
The cellular protooncogene c-fos and the immediate-early gene egr-1 are involved in developmental processes (22, 26) . c-fos and egr-2 show overlapping patterns of expression at ossification sites and in mesenchymally derived cells in the developing mouse (24). In contrast to our results with PGI,, it was shown that another prostanoid, PGE,, has the capacity to induce only c-fos mRNA in UMR 106-01 osteoblast-like cells, yet did not stimulate egr-1 mRNA (33).
To investigate the signal transduction pathways involved, we had to show, first, that the induction of c-fos expression by PGI, does not depend on de novo protein synthesis and, second, as expected, that it depends on new transcription. c-fos encodes for an unstable mRNA whose cytoplasmic lifespan is increased when translation is blocked by protein synthesis inhibitors (34, 35) , leading to the so-called superinduction phenomenon. More recently, the absolute requirement of translation for c-fos mRNA degradation was demonstrated (36). However, some inhibitors, such as CHX, act positively as nuclear signaling agonists and induce c-fos on their own (37).
Various PGs are known to induce cyclooxygenase isoenzymes, resulting in stimulation of the synthesis of PGH metabolites. The PGI, analog iloprost has the capacity to induce cyclooxygenase activity in MC3T3-El cells (14) . From this finding, one could speculate that PGI,-stimulated cyclooxygenase activity results in increased synthesis of other PG metabolites, which, in turn, are responsible for the stimulation of c-fos expression. We clearly can exclude such an indirect mechanism 1) because of the immediate c-fos mRNA accumulation by 10 min, which is less than the time necessary for cyclooxygenase activation (1 h) (14), 2) because treatment with the cyclooxygenase inhibitor indomethacin did not alter the c-fos response, and 3) because the experiments with CHX indicate that de nova protein synthesis is not obligatory.
The PGI, analog iloprost induces CAMP production in MC3T3-El cells, whereas inositol trisphosphate production was reported not to be significantly stimulated (14). In contrast, in Chinese hamster ovary cells, iloprost increased CAMP as well as the generation of inositol phosphates, indicating multiple signaling pathways (38). For arachidonic acid (31,39)-and PGE, (40)-induced c-fos induction, CAMPdependent as well as CAMP-independent mechanisms have been suggested. Treatment with H-7, an unspecific inhibitor of protein kinases, resulted in complete inhibition of the response. An additional series of experiments with phorbol ester (PMA) showed that PKC activity is not a necessary prerequisite for PGI,-mediated c-fos expression. The response to PGI, was also present after 24-h down-regulation of PKC by PMA. As a control at this time point, additional PMA treatment did not result in c-fos mRNA expression. Inhibition of adenylate cyclase with SQ22536 resulted in significant, but incomplete, inhibition of the effect of PGI, effect on c-fos expression (data not shown). We conclude from these data that among other protein kinases, CAMPdependent kinases play a role in PGI,-induced signal transduction to immediate-early gene expression.
The immediate-early transcription factors couple short term responses to long term alterations in gene expression. The induction of immediate-early genes is closely related to proliferation and/or differentiation (25). In our hands, PGI, exhibited mitogenic activities on MC3T3-El cells, as shown by [3H]thymidine incorporation. Its effect on proliferation after 24 h was as potent as that of PGE,.
In conclusion, we show that PGI, is an inducer of immediate-early genes in osteoblasts and other cells of mesenchyma1 origin and by this mechanism might influence the proliferation and differentiation of these cells.
